Search

everythinglearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia is a hair loss condition in postmenopausal women, similar to lichen planopilaris, with ineffective treatments.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

New treatments targeting skin stem cells show promise for skin repair, anti-aging, and cancer therapy.

A small number of premenopausal female blood donors had high prolactin levels, often due to stress, and retesting is recommended to prevent misdiagnosis.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

PCOS often causes acne, dark skin patches, excess hair, and hair loss, linked to hormone levels and obesity.

Some skin conditions may increase the risk of heart disease, but are not yet included in cardiovascular prevention guidelines.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

Hormonal treatments can help with acne, especially in women, by lowering androgen levels or blocking their effects.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

New acne treatments show promise as alternatives to traditional therapies.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Androgens play a key role in hair growth and disorders like baldness and excessive hairiness.

Dissolving microneedles offer efficient, minimally invasive drug delivery through the skin.

The document says that early treatment of Acne Vulgaris is important to prevent scarring and that adult onset acne is common in women, often due to hormonal imbalances.

Pubertal acne is linked to hormonal changes, affects quality of life, and is treated similarly to adult acne.

Hormonal imbalances can cause skin and hair problems in women, and treatments that block male hormones can help.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Updated treatments for female hair loss include minoxidil, antiandrogens, hair transplants, and light therapy.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Laser technologies improve medical treatments and outcomes.

Start acne treatment early to prevent scarring, consider antibiotic resistance, use maintenance therapy, and manage side effects carefully.